Pharmacotherapeutic management of COPD patients in Greece - Adherence to international guidelines

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 4, 2006, Pages 369-374

  Tsagaraki, V ^a   Markantonis, S L ^a,c   Amfilochiou, A ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

^c NONE

Author keywords

Chronic obstructive pulmonary disease; General Practitioner; Guidelines; Lung specialist; Prescriptions; Therapeutics

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; EXPECTORANT AGENT; LONG ACTING DRUG; SHORT ACTING DRUG; XANTHINE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EUROPE; GREECE; HUMAN; MEDICAL SPECIALIST; PATIENT CARE; PATIENT COMPLIANCE; PHARMACY; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY;

BRONCHODILATOR AGENTS; FAMILY PRACTICE; GREECE; GUIDELINE ADHERENCE; HUMANS; MEDICINE; PHYSICIAN'S PRACTICE PATTERNS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SPECIALIZATION; SPECIALTIES, MEDICAL;

EID: 33745967957     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00752.x     Document Type: Article

References (10)

1. Rudolf M (2000) The reality of drug use in COPD: the European perspective. Chest, 117 (Suppl. 2), 29S-32S.
2. Siafakas NM, Vermeire P, Pride NB et al. (1995) Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force. European Respiratory Journal, 8, 1398-1420.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) The GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. American Journal of Respiratory and Critical Care, 163, 1256-1276.
4. Pauwels RA, Lofdahl CG, Laitinen LA et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. New England Journal of Medicine, 340, 1948-1953.
5. Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. New England Journal of Medicine, 343, 1902-1909.
6. Burge PS, Calverley PMA, Jones PW et al. (2000) Randomised, double-blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease, the ISOLDE trial. BMJ, 320, 1297-1303.
7. Barnes PJ (2000) Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 161, 342-344.
8. Peperell K, Rudolf M, Pearson M, Diggle J (1997) General practitioner prescribing habits in asthma/COPD. Asthma in General Practice, 5, 29-30.
9. Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S (2000) Additive effects of salmeterol and fluticasone or theophylline in COPD. Chest, 118, 1576-1581.
10. Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T (2002) Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 166, 1084-1091.